Jilin Yisheng Pharmaceutical

Jilin Yisheng Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and commercialization of traditional Chinese medicines (TCM), particularly those derived from Panax ginseng and American ginseng. Based in Jilin Province, the company controls the entire value chain from cultivation and deep processing to the manufacturing of pharmaceutical drugs, health supplements, and cosmetics. Its flagship products, such as Zhenyuan Capsules and Xinyue Capsules, are widely used in China for treating cardiovascular and cerebrovascular conditions. The company is publicly listed on the Shenzhen Stock Exchange and is recognized as a key enterprise in the modernization of ginseng-based therapeutics.